Published in PLoS One on December 30, 2010
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol (2012) 2.19
Methodological and policy limitations of quantifying the saving of lives: a case study of the Global Fund's approach. PLoS Med (2013) 1.65
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One (2011) 1.49
The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS (2011) 1.38
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One (2013) 1.35
Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India. Interdiscip Perspect Infect Dis (2012) 1.17
Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis (2014) 1.11
Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med (2014) 1.11
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One (2012) 1.01
Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand. HIV AIDS (Auckl) (2012) 0.95
Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses (2013) 0.94
Prevalent tuberculosis and mortality among HAART initiators. AIDS (2012) 0.87
Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis. AIDS Res Ther (2013) 0.85
Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa. Afr Health Sci (2014) 0.83
Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential. AIDS (2012) 0.83
Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil. Int J Tuberc Lung Dis (2013) 0.83
Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand. Glob J Health Sci (2013) 0.83
The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis. PLoS One (2013) 0.80
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome. PLoS One (2013) 0.77
A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study. PLoS One (2015) 0.77
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease. PLoS One (2013) 0.77
The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa. BMC Public Health (2015) 0.76
Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa. PLoS One (2016) 0.75
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet (1999) 37.76
Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA (2006) 17.93
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet (2007) 9.71
Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis (2006) 9.25
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS (2005) 6.83
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS (2006) 5.87
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS (2001) 5.61
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20
Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med (2008) 5.17
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 4.45
Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med (2007) 3.32
Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med (1995) 3.09
Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol (2003) 3.09
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science (2003) 2.83
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.73
Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis (2001) 2.51
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. J Acquir Immune Defic Syndr (2007) 2.05
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis (2010) 1.91
Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis (1992) 1.76
A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis (1991) 1.65
Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS (2009) 1.56
Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis (2007) 1.49
Systematic reviews and meta-analyses: an illustrated, step-by-step guide. Natl Med J India (2004) 1.47
Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol (2007) 1.46
Global burden and epidemiology of tuberculosis. Clin Chest Med (2009) 1.35
Overstating the evidence: double counting in meta-analysis and related problems. BMC Med Res Methodol (2009) 1.33
Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS (2003) 1.29
Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS (2004) 1.26
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS (2008) 1.16
CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr (2009) 1.15
Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis. Trop Med Int Health (2005) 1.15
Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol (1997) 1.13
Predictors of survival in HIV-infected tuberculosis patients. AIDS (1996) 1.11
Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health (2009) 1.10
Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr (2009) 1.06
Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology. AIDS (1999) 1.06
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Diagnosing tuberculosis in HIV-infected patients: challenges and future prospects. Br Med Bull (2007) 0.97
Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion. J Acquir Immune Defic Syndr (2003) 0.90
Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival. Arch Intern Med (1997) 0.90
Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: should anergy be a criterion to start antiretroviral therapy in low-income countries? Am J Trop Med Hyg (2006) 0.89
Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count. Int J Tuberc Lung Dis (2004) 0.86
Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan. AIDS (1998) 0.85
Robert Koch and the discovery of the tubercle bacillus: the challenge of HIV and tuberculosis 125 years later. Int J Tuberc Lung Dis (2008) 0.82
The clinical significance of interactions between HIV and TB: more questions than answers. Int J Tuberc Lung Dis (2001) 0.82
Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study. Int J Tuberc Lung Dis (2009) 0.81
AIDS: "it's the bacteria, stupid!". Med Hypotheses (2008) 0.77
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study. Lancet (2006) 8.40
Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (2010) 7.07
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ (2011) 4.19
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One (2011) 3.57
The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases. BMC Genet (2006) 3.29
HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS (2008) 2.67
Prospects for tuberculosis elimination. Annu Rev Public Health (2012) 2.50
Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One (2007) 2.44
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J (2013) 2.20
HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes. BMJ (2010) 2.19
Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS (2009) 2.09
Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol (2012) 2.05
Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health (2005) 1.95
Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol Biochem Parasitol (2004) 1.71
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis (2013) 1.62
HIV, STIs, and sexual behaviors among men who have sex with men in Phnom Penh, Cambodia. AIDS Educ Prev (2004) 1.59
Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? BMC Infect Dis (2008) 1.58
Dengue as a cause of acute undifferentiated fever in Vietnam. BMC Infect Dis (2006) 1.53
Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis (2008) 1.51
Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One (2011) 1.49
Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A (2010) 1.48
Factors affecting severity of bicycle-related injuries: the role of helmets in preventing head injuries. Emerg Med Australas (2007) 1.47
Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42
Malaria control in Vietnam: the Binh Thuan experience. Trop Med Int Health (2005) 1.41
Acute undifferentiated fever in Binh Thuan province, Vietnam: imprecise clinical diagnosis and irrational pharmaco-therapy. Trop Med Int Health (2006) 1.37
Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001. Emerg Infect Dis (2006) 1.34
Infection control and the burden of tuberculosis infection and disease in health care workers in china: a cross-sectional study. BMC Infect Dis (2010) 1.31
Chronic diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome associated with HEp-2 adherent Escherichia coli in adults infected with human immunodeficiency virus in Bangui, Central African Republic. J Clin Microbiol (2002) 1.29
A community-based tuberculosis program in Cambodia. JAMA (2004) 1.21
HIV, HSV-2 and syphilis among married couples in India: patterns of discordance and concordance. Sex Transm Infect (2011) 1.20
Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood. BMC Infect Dis (2006) 1.18
Tuberculosis elimination in the Netherlands. Emerg Infect Dis (2005) 1.18
Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS One (2010) 1.17
Determining the burden of tuberculosis in Eritrea: a new approach. Bull World Health Organ (2007) 1.16
Secondary dengue virus type 4 infections in Vietnam. Southeast Asian J Trop Med Public Health (2005) 1.16
Insufficient quality of sputum submitted for tuberculosis diagnosis and associated factors, in Klaten district, Indonesia. BMC Pulm Med (2009) 1.16
Multidrug-resistant tuberculosis, People's Republic of China, 2007-2009. Emerg Infect Dis (2011) 1.15
Obstacles for optimal tuberculosis case detection in primary health centers (PHC) in Sidoarjo district, East Java, Indonesia. BMC Health Serv Res (2007) 1.13
Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study. BMC Public Health (2010) 1.12
Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options. Sex Transm Dis (2006) 1.10
Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, Ethiopia. Trop Med Int Health (2004) 1.05
Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J (2012) 1.03
Vitamin D deficiency among healthy adolescents in Al Ain, United Arab Emirates. BMC Public Health (2013) 1.02
Monitoring cause-specific adult mortality in developing countries: a comparison of data sources for Addis Ababa and its implications for policy and research. Soc Sci Med (2005) 1.02
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One (2012) 1.01
The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine (2011) 1.00
Reaching the global tuberculosis control targets in the Western Pacific Region. Bull World Health Organ (2007) 1.00
Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review. Eur Respir J (2013) 0.98
Favorable changes in lipid profile: the effects of fasting after Ramadan. PLoS One (2012) 0.97
Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality. AIDS (2014) 0.97
Thyrotrophin and free thyroxine trimester-specific reference intervals in a mixed ethnic pregnant population in the United Arab Emirates. Clin Chim Acta (2006) 0.97
Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China. BMC Health Serv Res (2011) 0.96
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J (2012) 0.94
Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Euro Surveill (2016) 0.94
Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Int J Tuberc Lung Dis (2011) 0.94
Combining matched and unmatched control groups in case-control studies. Am J Epidemiol (2008) 0.94
Spatial clustering analysis in neuroanatomy: applications of different approaches to motor nerve fiber distribution. J Neurosci Methods (2006) 0.94
Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses. Eur J Epidemiol (2006) 0.93
Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment. Clin Epidemiol (2011) 0.93
Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals. J Med Microbiol (2012) 0.93
Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study. AIDS (2002) 0.91
Automated detection of malaria pigment: feasibility for malaria diagnosing in an area with seasonal malaria in northern Namibia. Trop Med Int Health (2006) 0.90
Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence (2009) 0.89
Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Infect Dis (2011) 0.89
The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia. Am J Trop Med Hyg (2010) 0.89
Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review. PLoS One (2013) 0.88
Male use of female sex work in India: a nationally representative behavioural survey. PLoS One (2011) 0.88
Improving detection and notification of tuberculosis cases in students in Shaanxi province, China: an intervention study. BMC Public Health (2011) 0.88
An outbreak of food-borne illness associated with methomyl-contaminated salt. JAMA (2002) 0.88
Metabolic syndrome among Emirati adolescents: a school-based study. PLoS One (2013) 0.87
β-Thalassemia in Abu Dhabi: consanguinity and tribal stratification are major factors explaining the high prevalence of the disease. Hemoglobin (2013) 0.86
A common human leucocyte antigen-DP genotype is associated with resistance to HIV-1 infection in Kenyan sex workers. AIDS (2008) 0.85
UAE population reference standard charts for body mass index and skinfold thickness, at ages 0-18 years. Int J Food Sci Nutr (2011) 0.84
Space-time cluster analysis of invasive meningococcal disease. Emerg Infect Dis (2004) 0.84
Milk, chocolate and Nobel prizes: potential role of lactose intolerance and chromosome 2. Evid Based Med (2013) 0.84
Half of the Emirati population has abnormal red cell parameters: challenges for standards and screening guidelines. Hemoglobin (2013) 0.83
Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study. Diabetes Technol Ther (2012) 0.83
Randomised primary health center based interventions to improve the diagnosis and treatment of undifferentiated fever and dengue in Vietnam. BMC Health Serv Res (2010) 0.83
Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur Respir J (2013) 0.83
HIV postexposure prophylaxis in an urban population of female sex workers in Nairobi, Kenya. J Acquir Immune Defic Syndr (2013) 0.82
[Sensitivity and specificity of the BCG scar reading]. Rev Saude Publica (2003) 0.82
WHO guidance on electronic systems to manage data for tuberculosis care and control. J Am Med Inform Assoc (2012) 0.82
GFR estimation in the morbidly obese pre- and postbariatric surgery: one size does not fit all. Int Urol Nephrol (2012) 0.81
Comparison between short- and long-acting erythropoiesis-stimulating agents in hemodialysis patients: target hemoglobin, variability, and outcome. Int Urol Nephrol (2014) 0.81
Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS (2016) 0.81
Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002‒2011. Euro Surveill (2015) 0.80
Prevalence and impact of premenstrual syndrome in adolescent schoolgirls in the United Arab Emirates. Acta Obstet Gynecol Scand (2006) 0.80
Trends in Adult Chlamydia and Gonorrhea Prevalence, Incidence and Urethral Discharge Case Reporting in Morocco over 1995-2015-Estimates Using the Spectrum-Sexually Transmitted Infection Model. Sex Transm Dis (2017) 0.80
Parental weight perceptions: a cause for concern in the prevention and management of childhood obesity in the United Arab Emirates. PLoS One (2013) 0.79
Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs. AIDS Res Hum Retroviruses (2005) 0.79
Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach. Stat Appl Genet Mol Biol (2008) 0.78
Biomarkers for sexual behaviour change: a role for nonpaternity studies? AIDS (2014) 0.78
Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance. Scand J Infect Dis (2011) 0.77